(Q35756852)

10 August 2017

1 reference

title

Promoter of TRAIL-R2 gene (English)

1 reference

10 August 2017

Tatsushi Yoshida

1

1 reference

10 August 2017

Toshiyuki Sakai

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

published in

Vitamins and Hormones

1 reference

10 August 2017

volume

67

1 reference

10 August 2017

page(s)

35-49

1 reference

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Expression of the mouse HPRT gene: deletional analysis of the promoter region of an X-chromosome linked housekeeping gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Promoter structure of the mouse TATA-binding protein (TBP) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

[Molecular cancer epidemiology--the present status and future possibilities]

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Butyrate as a model for "gene-regulating chemoprevention and chemotherapy.".

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967003-8

7 January 2021

10.1016/S0083-6729(04)67003-8

Identifiers

DOI

1 reference

10 August 2017

1 reference